Showing results (351-360 of 475) with videos related to

Sort By:
Pageof 48
Infection & Chemotherapy|January 4, 2020
Erratum: Carbapenem-Resistant Enterobacteriaceae: Prevalence and Risk Factors in a Single Community-Based Hospital in KoreaHyo Jin Lee, Jae Ki Choi, Sung Yeon Cho, et al.
Human Vaccines & Immunotherapeutics|December 15, 2016
Comparative evaluation of a newly developed 13-valent pneumococcal conjugate vaccine in a mouse modelChulmin Park, Eun-Young Kwon, Su-Mi Choi, et al.
Journal of Korean Medical Science|April 16, 2005
Vancomycin-resistant enterococcal bacteremia in a hematology unit: molecular epidemiology and analysis of clinical courseJin-Hong Yoo, Dong-Gun Lee, Su Mi Choi, et al.
Infection & Chemotherapy|September 24, 2016
Carbapenem-resistant Enterobacteriaceae: Prevalence and Risk Factors in a Single Community-Based Hospital in KoreaHyo Jin Lee, Jae Ki Choi, Sung Yeon Cho, et al.
Plos One|September 3, 2020
Prognostic factors of cytomegalovirus retinitis after hematopoietic stem cell transplantationJoo Young Kim, Seo-Yeon Hong, Woo Kyung Park, et al.
Biochemical and Biophysical Research Communications|May 7, 2014
Neurotropic and neuroprotective activities of the earthworm peptide LumbricusinDae Hong Kim, Ik Hwan Lee, Seung Taek Nam, et al.
International Journal of Molecular Sciences|October 16, 2024
SARS-CoV-2-Specific T-Cell as a Potent Therapeutic Strategy against Immune Evasion of Emerging COVID-19 VariantsKeon-Il Im, Nayoun Kim, Junseok Lee, et al.
Vaccines|October 28, 2023
Longitudinal Analysis of SARS-CoV-2-Specific Cellular and Humoral Immune Responses and Breakthrough Infection following BNT162b2/BNT162b2/BNT162b2 and ChAdOx1/ChAdOx1/BNT162b2 Vaccination: A Prospective Cohort in Naive Healthcare WorkersGeon Young Ko, Jihyun Lee, Hyunjoo Bae, et al.
Yonsei Medical Journal|April 2, 2020
Comparison of In Vivo Pharmacokinetics and Pharmacodynamics of Vancomycin Products Available in KoreaHee Kyung Kim, Su Mi Choi, Gaeun Kang, et al.
Cancer|January 2, 2009
The extent of minimal residual disease reduction after the first 4-week imatinib therapy determines outcome of allogeneic stem cell transplantation in adults with Philadelphia chromosome-positive acute lymphoblastic leukemiaSeok Lee, Yoo-Jin Kim, Nak-Gyun Chung, et al.
Pageof 48